281 related articles for article (PubMed ID: 32857242)
1. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
[TBL] [Abstract][Full Text] [Related]
2. Ipsilateral and Concurrent Breast Cancer and Atypical Ductal Hyperplasia: Does Atypia Also Need Surgical Excision?
Amin AL; Fan F; Winblad OD; Larson KE; Wagner JL
Ann Surg Oncol; 2020 Nov; 27(12):4786-4794. PubMed ID: 32705514
[TBL] [Abstract][Full Text] [Related]
3. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.
Chen LY; Hu J; Tsang JYS; Lee MA; Ni YB; Chan SK; Tse GMK
Histopathology; 2019 Sep; 75(3):320-328. PubMed ID: 31013355
[TBL] [Abstract][Full Text] [Related]
5. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
6. Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study.
Uzoaru I; Morgan BR; Liu ZG; Bellafiore FJ; Gaudier FS; Lo JV; Pakzad K
Virchows Arch; 2012 Oct; 461(4):419-23. PubMed ID: 22961104
[TBL] [Abstract][Full Text] [Related]
7. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
8. Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.
Williams KE; Amin A; Hill J; Walter C; Inciardi M; Gatewood J; Redick M; Wick J; Hunt S; Winblad O
Acad Radiol; 2019 Jul; 26(7):893-899. PubMed ID: 30318287
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.
Co M; Kwong A; Shek T
Int J Surg; 2018 Jan; 49():27-31. PubMed ID: 29146271
[TBL] [Abstract][Full Text] [Related]
10. Atypical ductal hyperplasia on core needle biopsy: Development of a predictive model stratifying carcinoma upgrade risk on excision.
Salagean ED; Slodkowska E; Nofech-Mozes S; Hanna W; Parra-Herran C; Lu FI
Breast J; 2019 Jan; 25(1):56-61. PubMed ID: 30461131
[TBL] [Abstract][Full Text] [Related]
11. Is the upgrade rate of atypical ductal hyperplasia diagnosed by core needle biopsy of calcifications different for digital and film-screen mammography?
McLaughlin CT; Neal CH; Helvie MA
AJR Am J Roentgenol; 2014 Oct; 203(4):917-22. PubMed ID: 25247961
[TBL] [Abstract][Full Text] [Related]
12. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.
Peña A; Shah SS; Fazzio RT; Hoskin TL; Brahmbhatt RD; Hieken TJ; Jakub JW; Boughey JC; Visscher DW; Degnim AC
Breast Cancer Res Treat; 2017 Jul; 164(2):295-304. PubMed ID: 28474262
[TBL] [Abstract][Full Text] [Related]
13. Type of Architecture, Presence of Punctate Necrosis, and Extent of Involvement in Atypical Ductal Hyperplasia Can Predict the Diagnosis of Breast Carcinoma on Excision: A Clinicopathologic Study of 143 Cases.
Zhang C; Wang EY; Liu F; Ruhul Quddus M; James Sung C
Int J Surg Pathol; 2021 Oct; 29(7):716-721. PubMed ID: 33881947
[TBL] [Abstract][Full Text] [Related]
14. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
Wagoner MJ; Laronga C; Acs G
Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates.
Tozbikian G; George M; Zynger DL
Diagn Pathol; 2019 Jun; 14(1):69. PubMed ID: 31253155
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
17. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.
Vandenbussche CJ; Khouri N; Sbaity E; Tsangaris TN; Vang R; Tatsas A; Cimino-Mathews A; Argani P
Am J Surg Pathol; 2013 Jun; 37(6):913-23. PubMed ID: 23598968
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.
Chae BJ; Lee A; Song BJ; Jung SS
World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
20. Upgrade Rate of Atypical Ductal Hyperplasia: Ten Years Experience and Predictive Factors.
Gagnon N; Martel E; Cadrin-Chênevert A; Ledoux E; Racicot C; Villiard R
J Surg Res; 2021 Oct; 266():311-318. PubMed ID: 34044175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]